Order Article Reprints

Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N, et al. Dopamine D₁ Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease. Biomolecules. 2023; 13(5):829. https://doi.org/10.3390/biom13050829

Lewis, Mechelle M., Lauren J. Van Scoy, Sol De Jesus, Jonathan G. Hakun, Paul J. Eslinger, Julio Fernandez-Mendoza, Lan Kong, Yang Yang, Bethany L. Snyder, Natalia Loktionova, and et al. 2023. "Dopamine D₁ Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease" Biomolecules 13, no. 5: 829. https://doi.org/10.3390/biom13050829

Lewis, M. M., Van Scoy, L. J., De Jesus, S., Hakun, J. G., Eslinger, P. J., Fernandez-Mendoza, J., Kong, L., Yang, Y., Snyder, B. L., Loktionova, N., Duvvuri, S., Gray, D. L., Huang, X., & Mailman, R. B. (2023). Dopamine D₁ Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease. Biomolecules, 13(5), 829. https://doi.org/10.3390/biom13050829